To strengthen its service team with highly qualified Doctors and Healthcare professionals.
New Delhi, January 20, 2018: One of the leading global Pharmacovigilance provider companies today announced the launch of its new state-of-the-art global services delivery center-in Ahmedabad. The company offers comprehensive services in drug safety, medical information, regulatory, quality assurance and technology services to companies in the life sciences industry. APCER, on behalf of our life sciences clients provides drug safety reporting to regulatory authorities in more than 100 countries from its centers across India, Princeton, London and Hong Kong.
APCER is strengthening its service team with highly qualified doctors and healthcare professionals in Ahmedabad to add to its strength of 700 full time employees. Uniquely, more than 15% of APCER employees are qualified physicians and 90% are healthcare professionals. The new center is set to expand and upscale its services to global pharmaceutical, biologics, medical device and consumer product companies with a world class team of scientific experts, focused on delivering value to their clients.
Speaking at the launch, Mr. Ravi Menon, Chairman, said, “Our vision behind the new state-of-the-art global services delivery center in Ahmedabad is to help our life sciences clients, not just comply but be assured of surpassing drug safety regulations by integrating the latest innovations, technology and digital transformation to support the pharmaceutical companies with ever changing regulations.”
Mr. Gopal Menon, Vice-Chairman, said, “Understanding the life sciences landscape and needs of pharmaceutical companies to cope up with the changing regulatory environment, APCER is taking proactive steps by embedding global and harmonized processes in its framework.”
Mr. Kunwar Arora, Global Chief Operating Officer and MD India, said, “To manage business growth the expansion in Ahmedabad is vital for our organisation. Ahmedabad offers the most suitable medical talent in the country. This global services delivery center will increase our talent base by 25%. APCER is progressing towards outcome based models and ensuring benefits delivered to our customers. Our comprehensive expansion of expertise in all key therapeutic areas will be a significant value add to global clients. With our initiative to co-create intellectual properties with technology partners we are entering into next phase of significant growth and expansion.
APCER provides global infrastructure and scientific / medical experts, supported by integrated processes and regulatory-compliant technology systems. The organization has proven to be responsive and scalable to the demands of life sciences, pharmaceutical, biotechnology, medical device, consumer product companies. APCER has been delivering unmatchable customised solution for drug safety, disease management programs, medical monitoring, regulatory operations, medical affairs, medical writing and quality assurance and auditing services with commitment to safety that has gone beyond compliance.
Corporate Comm India(CCI Newswire)
